Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

FLUOR DE LYS®-SIRT1 deacetylase substrate

BML-KI177-0005 0.5 µmol 210.00 USD
Do you need bulk/larger quantities?
FLUOR DE LYS®-SIRT1 is a fluorogenic, acetylated peptide substrate for SIRT1 (human Sirtuin 1). Based on residues 379-382 of p53 (Arg-His-Lys-Lys(Ac)), a site of regulatory acetylation by the p300 and CBP acetyltransferases (lysines 381, 382), it was the best substrate for SIRT1 from among a panel of substrates patterned on p53, histone H3, and histone H4 acetylation sites. FLUOR DE LYS®-SIRT1 is deacetylated by SIRT1 (BML-SE239) at a rate of more then 8-fold that of the acetylated lysine substrate, FLUOR DE LYS® (Prod. No. BML-KI104; acetylated substrates both at 25 µM, 500 µM NAD+). The Km of FLUOR DE LYS®-SIRT1 for human recombinant Sirtuin 1 is 108 µM (determined at 37°C, 500 µM NAD+). Must be used in conjunction with FLUOR DE LYS® Developer II (Prod. No. BML-KI176). Fluorescent signal indicates deacetylation of Lys382. Sufficient for 100-200 assays of human recombinant SIRT1 (1U/well, 50-100 µM substrate).

Product Specification

Quantity:0.5 µmol (100 µl)
Formulation:Supplied as a 5 mM solution in HDAC Assay Buffer.
Purity:≥95% (HPLC)
Shipping:Shipped on Dry Ice
Long Term Storage:-80┬░C

Product Literature References

Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD+-Binding Site: P. Mellini, et al.; J. Med. Chem. 62, 5844 (2019), Abstract;
Pharmacophore modeling and virtual screening studies to identify novel selective SIRT2 inhibitors: G. Eren, et al.; J. Mol. Graph. Model. 10, 1313 (2019), Abstract;
Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects: P. Trivedi, et al.; Eur. J. Pharm. Sci. 124, 165 (2018), Abstract;
Two Novel Proline-Containing Catechin Glucoside from Water-Soluble Extract of Codonopsis pilosula: F.Y. Qin, et al.; Molecules 23, E180 (2018), Application(s):SIRT1 Inhibition, Abstract; Full Text
Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease: R. Kuma, et al.; Eur. J. Med. Chem. 127, 909 (2017), Abstract;
Human histone deacetylase 6 shows strong preference for tubulin dimers over assembled microtubules: L. Skultetyova, et al.; Sci. Rep. 7, 11547 (2017), Abstract; Full Text
BET Inhibition Upregulates SIRT1 and Alleviates Inflammatory Responses: T. Kokkola, et al.; Chembiochem 16, 1997 (2015), Abstract; Full Text
AROS has a context-dependent effect on SIRT1: T. Kokkola, et al.; FEBS Lett. 2, 588 (2014), Abstract;
Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors: W.H. Huang, et al.; Eur. J. Med. Chem. 46, 4042 (2011), Abstract;

General Literature References

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation: A. Ito, et al.; EMBO J. 21, 6236 (2002), Abstract;
Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases: N.A. Barletv, et al.; Mol. Cell 8, 1243 (2001), Abstract;
p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2: A. Ito, et al.; EMBO J. 20, 1331 (2001), Abstract;
p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage: L. Liu, et al.; Mol. Cell. Biol. 19, 1202 (1999), Abstract;
DNA damage activates p53 through a phosphorylation-acetylation cascade: K. Sakaguchi, et al.; Genes Dev. 12, 2831 (1998), Abstract;
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain: W. Gu, et al.; Cell 90, 595 (1997), Abstract;

Related Products

SIRT1 (human), (recombinant) (His-tag) 

Highly active
Produced in E. coli. Recombinant SIRT1 from human cDNA containing an N-terminal His-tag. | Print as PDF
BML-SE239-0100 100 U 351.00 USD
Do you need bulk/larger quantities?

FLUOR DE LYS® deacetylase substrate 

Highly sensitive and convenient alternative to radiolabeled, acetylated histones or peptide/HPLC methods for the assay of histone deacetylases.
≥95% (HPLC) | Print as PDF
BML-KI104-0050 50 µl 170.00 USD
Do you need bulk/larger quantities?

FLUOR DE LYS® developer II concentrate 

Print as PDF
BML-KI176-1250 1.25 ml 214.00 USD
Do you need bulk/larger quantities?


Syk inhibitor. SIRT1 activator.
10083-24-6, Synthetic., ≥98% (HPLC (UV)) | Print as PDF
ALX-270-202-M001 1 mg 40.00 USD
ALX-270-202-M005 5 mg 69.00 USD
ALX-270-202-M010 10 mg 122.00 USD
ALX-270-202-M050 50 mg 454.00 USD
Do you need bulk/larger quantities?

FLUOR DE LYS® SIRT1 fluorometric drug discovery assay kit 

First-to-market by the leader in Epigenetics research tools
Fluorescent detection, HTS, Activity assay, Cell-based assays | Print as PDF
BML-AK555-0001 96 wells 676.00 USD
Do you need bulk/larger quantities?


Antioxidant. SIRT1 activator.
501-36-0, ≥98% (HPLC) | Print as PDF
BML-FR104-0100 100 mg 60.00 USD
BML-FR104-0500 500 mg 256.00 USD
Do you need bulk/larger quantities?

SIRT1 (human) polyclonal antibody 

Purified from rabbit serum., IHC (PS), WB | Print as PDF
BML-SA427-0100 100 µl 329.00 USD
Do you need bulk/larger quantities?

Related Literature

Stem Cells
Stem Cells
Download as PDF

Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,